Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 78 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 6749856

    Mucosal cytotoxic T lymphocyte responses

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 15, 2004 · Expires Jun 10, 2024

    expired
  2. US 6747055

    Water-soluble drugs and methods for their production

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 8, 2004 · Expires Jun 3, 2024

    expired
  3. US 6743577

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 1, 2004 · Expires May 27, 2024

    expired
  4. US 6743626

    Artificial salivary gland

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 1, 2004 · Expires May 27, 2024

    expired
  5. US 6737511

    Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2004 · Expires May 13, 2024

    expired
  6. US 6737251

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2004 · Expires May 13, 2024

    expired
  7. US 6734014

    Methods and compositions for transforming dendritic cells and activating T cells

    The United States of America, as represented by the Department of Health and Human Services · Granted May 11, 2004 · Expires May 6, 2024

    expired
  8. US 6719978

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 13, 2004 · Expires Apr 8, 2024

    expired
  9. US 6713066

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

    expired
  10. US 6713081

    Ocular therapeutic agent delivery devices and methods for making and using such devices

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

    expired
  11. US 6710166

    41 kDa Cryptosporidium parvum oocyst wall protein

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 23, 2004 · Expires Mar 18, 2024

    expired
  12. US 6709842

    DNA encoding a growth factor specific for epithelial cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 23, 2004 · Expires Mar 18, 2024

    expired
  13. US 6706873

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 16, 2004 · Expires Mar 11, 2024

    expired
  14. US 6699842

    Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

    expired
  15. US 6699835

    Formulation of boronic acid compounds

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

    expired
  16. US 6696562

    Avian astrovirus

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  17. US 6696242

    Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  18. US 6696064

    Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  19. US 6689560

    Raf protein kinase therapeutics

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  20. US 6689383

    Chromium-histidine complexes as nutrient supplements

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  21. US 6689367

    Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  22. US 6685948

    Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired
  23. US 6685944

    Modified HCV peptide vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired
  24. US 6685949

    Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired